Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Fisher & Paykel Healthcare Corporation Provides FY 2022 Revenue Guidance

23 Mar 2022  |  07:34:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Fisher & Paykel Healthcare provides FY22 revenue guidance

Fisher & Paykel Healthcare Corporation provided revenue guidance for the financial year ending 31 March 2022. At current exchange rates, the Company expects full-year operating revenue for the 2022 financial year to be in the range of $1.675bn to $1.70bn. Freight rates remain elevated and for the 2022 financial year are expected to impact its long term gross margin target of 65% by 250 basis points.

Please click here for full details

See more ASX300 News Announcements